Thessaloniki

• Study of Nemolizumab for the treatment of adults with systemic sclerosis Pending
  2025-522294-11-00 4 Systemic sclerosis
• A Study to Test How Well ZL-1310 may Work Compared to Therapies Selected by the Investigator in Treating Patients with Relapsed Small Cell L … Pending
  2025-522818-23-00 5 Small Cell Lung Cancer (SCLC)
• Supporting weak immune system during autoimmune therapy: testing Panzyga to prevent infections Pending
  2025-522854-37-00 5 Prevention of a Major infection in patients with Hypogammaglobulinemia
• A Study for Comparing a Generic Combination of Brimonidine and Timolol Eye Drops versus Combigan® Eye Drops in the Treatment of Patients wit … Pending
  2025-523227-22-00 5 Ocular Hypertension
• A Phase 3 extension study to assess the long-term safety and efficacy of remibrutinib in adult participants with moderate to severe hidraden … Pending
  2025-523259-72-00 5 Hidradenitis Suppurativa (HS)
• A study to find out how nerandomilast is tolerated, handled by the body, and if it helps children and adolescents with interstitial lung dis … Pending
  2025-523369-32-00 5 Fibrosing interstitial lung disease
• A clinical study to investigate the safety and tolerability of efimosfermin alfa injection in participants with known or suspected F2- or F3 … Pending
  2025-523674-16-00 5 Metabolic Dysfunction-Associated Steatohepatitis (MASH)
• A pivotal clinical study to investigate the safety and efficacy of efimosfermin alfa injection in participants with biopsyconfirmed F2- or F … Pending
  2025-523675-39-00 5 Metabolic Dysfunction-Associated Steatohepatitis (MASH)
• Comparison of weekly Somatrogon to daily Genotropin in children born small for gestational age or with idiopathic short stature. Pending
  2025-523832-38-00 5 Small for gestational age (SGA) and idiopathic short stature (ISS)
• A Study of Enpatoran in Cutaneous Manifestations of Lupus With or Without Systemic Disease Pending
  2025-523871-44-00 5 Cutaneous Manifestations of Lupus Erythematosus With or Without System
• Cevostamab in Combination with Pomalidomide and Dexamethasone Versus Standard of Care in Patients with Previously Treated Multiple Myeloma Pending
  2025-524028-23-00 5 Multiple Myeloma
• A study of BV100 plus low dose polymyxin B for treating hospital -acquired and ventilator-associated pneumonia caused by antibiotic resistan … Pending
  2025-524092-23-00 5 Hospital-acquired bacterial pneumonia including ventilator-associated
• A study that will check the safety, tolerability and effectiveness of the study drug (OMN6), as well as how the body responds to it after a … Pending
  2025-524200-29-00 4 Hospital-acquired bacterial pneumonia or ventilated-associated bacteri
• THE ROLE OF PANCREATIC STONE PROTEIN (PSP) AND PSP-GUIDED EARLY MEROPENEM TREATMENT TO MITIGATE SEPSIS RISK AT THE EMERGENCY DEPARTMENT: TH … Pending
  2025-525006-37-00 5 Infection and sepsis
• A Phase 2/3 Study of EIK1001 in Combination with Pembrolizumab and Chemotherapy in Participants with Stage 4 Non-Small Cell Lung Cancer. Pending
  2025-525013-23-00 4 Stage 4 (IV) Non-Small Cell Lung Cancer (NSCLC)
• CLARITHROMYCIN TO PREVENT SECONDARY INFECTIONS IN PATIENTS WITH SEPSIS FOLLOWING LOWER RESPIRATORY TRACT INFECTIONS: THE CLASSIFY TRIAL Pending
  2025-525058-20-00 5 Community- acquired pneumonia related sepsis with evidence of Sepsis I
• A Study to Evaluate a New Treatment Option for Helicobacter pylori Infection Compared to First Line Treatment. Recruiting
  2026-525291-26-00 5 2026-07-07 Helicobacter Pylori Infection
• A study to Assess Intravenous (IV) Telisotuzumab Adizutecan in Combination with IV Bevacizumab Compared to Standard of Care IV Bevacizumab i … Recruiting
  2025-521712-19-00 5 2026-07-06 Colorectal Cancer
• A study of LY4268989 in participants with Moderately to Severely Active Ulcerative Colitis (EMERALD-3) Recruiting
  2025-524404-29-00 4 2026-06-24 Ulcerative Colitis, Active Moderate
• DAREON®-Lung-1: A study in people with advanced small cell lung cancer to compare obrixtamig plus atezolizumab, carboplatin, and etoposide t … Recruiting
  2025-520565-51-00 5 2026-06-23 small cell lung cancer
• A clinical trial of V940 with or without MK-3475A in people with non-small cell lung cancer (V940-014) Recruiting
  2025-522643-18-00 5 2026-06-16 Stage I NSCLC
• A study to evaluate the efficacy and safety of belantamab mafodotin in combination with standard of care in participants aged 18 years and o … Recruiting
  2025-523117-28-00 4 2026-06-12 Relapsed or Refractory Multiple Myeloma
• A Study of Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants with Unresectable Stage III NSCLC Recruiting
  2025-523576-23-00 5 2026-06-12 Unresectable Stage III non-small cell lung cancer without progression
• A Phase 3 Study of Orelabrutinib in Patients with Primary Progressive Multiple Sclerosis Recruiting
  2025-524316-11-00 5 2026-06-11 Primary Progressive Multiple Sclerosis (PPMS)

Showing 25–48 of 655 trials